ABSTRACT
In recent years, great progress has been made in artificial intelligence and radiomics applications to serve human health. The goal of this paper is to provide an overview of current artificial intelligence and radiomics applications in thoracic surgery.
Keywords: Thoracic Surgery, Artificial Intelligence, Radiomics
References
1
Russell SJ, Norvig P. Artificial intelligence: a modern approach. 2nd ed. Upper Saddle River, N.J.: Prentice Hall/Pearson Education; 2003.
2
Shameer K, Johnson KW, Glicksberg BS, et al. Machine learning in cardiovascular medicine: are we there yet? Heart. 2018;104:1156-1164.
3
Johnson KW, Torres Soto J, Glicksberg BS, et al. Artificial Intelligence in Cardiology. J Am Coll Cardiol. 2018;71:2668-2679.
4
Zheng M. Classification and Pathology of Lung Cancer. Surg Oncol Clin N Am. 2016;25:447-468.
5
Yoneda K, Imanishi N, Ichiki Y, et al. Treatment of Non-small Cell Lung Cancer with EGFR-mutations. J UOEH. 2019;41:153-163.
6
Lin CY, Chang CC, Chu CY, et al. Computed Tomography-Guided Transthoracic Needle Biopsy: Predictors for Diagnostic Failure and Tissue Adequacy for Molecular Testing. Front Med (Lausanne). 2021;8:650381.
7
Hong D, Xu K, Zhang L, et al. Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma. Front Oncol. 2020;10:28.
8
Kahya Y, Orhan K, Buyukceran EU, et al. EP13.01-002 Radiomic Signature on CT Images: A Noninvasive Biomarker for Pretreatment Discrimination of EGFR Mutations in NSCLC Patients. Journal of Thoracic Oncology. 2022;17:S519-S520.
9
Yoon J, Suh YJ, Han K, et al. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas. Thorac Cancer. 2020;11:993-1004.
10
Kahya Y, Orhan K, Kocaman G, et al. BT Tabanlı Radiomics, Küçük Hücreli Dışı Akciğer Kanserinde PD-L1 Mutasyon Varlığını Belirlemede Noninvaziv Bir Biyobelirteç Olabilir Mi? SS-104, TÜSAD 44.Uluslararası Katılımlı Yıllık Kongresi, 5-10 Kasım 2022, KKTC.
11
Jones CM, Brunelli A, Callister ME, Franks KN. Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence? Curr Surg Rep. 2018;6:5.
12
Ma X, Xia L, Chen J, et al. Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model. Eur Radiol. 2022.
13
He L, Huang Y, Yan L et al. Radiomics-based predictive risk score: a scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer. Chin J Cancer Res. 2019;31:641-652.
14
Zhong Y, Yuan M, Zhang T, et al. Radiomics Approach to Prediction of Occult Mediastinal Lymph Node Metastasis of Lung Adenocarcinoma. AJR Am J Roentgenol. 2018;211:109-113.
15
Meyer HJ, Leonhardi J, Höhn AK, Pappisch J, Wirtz H, Denecke T, Frille A. CT Texture Analysis of Pulmonary Neuroendocrine Tumors-Associations with Tumor Grading and Proliferation. J Clin Med. 2021;10:5571.
16
Kayı Cangır A, Orhan K, Kahya Y, Kavak KA, Dursun Ş, Yücemen AU, Karasoy D, Uzun Ç. Pulmoner karsinoid tümörlerin tipik/atipik ayrımında BT tabanlı makine öğrenim modeli. SSB-027, TGCD 11.Ulusal Göğüs Cerrahisi Kongresi, 24-27 Ekim 2021, Antalya, Türkiye.
17
Kayi Cangir A, Orhan K, Kahya Y, et al. A CT-Based Radiomic Signature for the Differentiation of Pulmonary Hamartomas from Carcinoid Tumors. Diagnostics (Basel). 2022;12:416.
18
Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, Miyoshi T, Sakiyama S, Mukai K, Monden Y. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004;77:1183-1188.
19
Kayi Cangir A, Orhan K, Kahya Y, et al. CT imaging-based machine learning model: a potential modality for predicting low-risk and high-risk groups of thymoma:“Impact of surgical modality choice”. World J Surg Oncol. 2021;19:147.
20
Gürsoy Çoruh A, Yenigün B, Uzun Ç, et al. A comparison of the fusion model of deep learning neural networks with human observation for lung nodule detection and classification. Br J Radiol. 2021;94:20210222.
